Drug profile · INN
olipudase alfa
XENPOZYME
olipudase alfa (XENPOZYME) is a sphingomyelin hydrolytic enzyme.
EMA: approved PMDA: approved Alimentary tract and metabolism (A16) A16AB25
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — olipudase alfa
- Class
- Alimentary tract and metabolism (A16)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
olipudase alfa (XENPOZYME) is a sphingomyelin hydrolytic enzyme.
Key facts
INN olipudase alfa
Brand XENPOZYME
Mechanism Sphingomyelin hydrolytic enzyme
Target Sphingomyelin
Therapeutic class Alimentary tract and metabolism (A16)
ATC code A16AB25
Mechanism of action
Sphingomyelin hydrolytic enzyme
Primary target: Sphingomyelin
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is olipudase alfa?
olipudase alfa (XENPOZYME) is a sphingomyelin hydrolytic enzyme.
What is the brand name for olipudase alfa?
XENPOZYME is a marketed brand name for olipudase alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.